2023 Q1 Form 10-Q Financial Statement

#000121390023012758 Filed on February 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $623.1K $606.2K $402.1K
YoY Change 68.45% 50.74% -46.17%
Cost Of Revenue $514.9K $511.2K $307.3K
YoY Change 59.9% 66.36% 9.67%
Gross Profit $108.2K $94.95K $94.82K
YoY Change 126.03% 0.14% -79.69%
Gross Profit Margin 17.36% 15.66% 23.58%
Selling, General & Admin $481.5K $514.3K $654.3K
YoY Change -12.06% -21.4% -17.0%
% of Gross Profit 445.09% 541.64% 690.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change -100.0%
% of Gross Profit 0.0%
Operating Expenses $481.5K $514.3K $654.3K
YoY Change -12.06% -21.4% -17.26%
Operating Profit -$373.3K -$419.3K -$559.5K
YoY Change -25.29% -25.05% 72.71%
Interest Expense -$457.4K -$362.3K -$293.5K
YoY Change 53.41% 23.46% -34.64%
% of Operating Profit
Other Income/Expense, Net -$457.4K -$362.3K -$293.5K
YoY Change 105.07% 23.46%
Pretax Income -$830.7K -$781.7K -$853.0K
YoY Change 14.94% -8.36% -4250.71%
Income Tax
% Of Pretax Income
Net Earnings -$830.7K -$781.7K -$853.0K
YoY Change 14.94% -8.36% -4250.71%
Net Earnings / Revenue -133.31% -128.95% -212.12%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$329.30
COMMON SHARES
Basic Shares Outstanding 6.621B shares 5.864B shares 2.590B shares
Diluted Shares Outstanding 6.527B shares 5.327B shares 2.590B shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.15K $94.94K $781.7K
YoY Change -97.38% -87.86% 463.34%
Cash & Equivalents $10.15K $94.94K $781.7K
Short-Term Investments
Other Short-Term Assets $4.660K $4.660K $7.120K
YoY Change -5.48% -34.55% -27.49%
Inventory $83.84K $92.37K $69.46K
Prepaid Expenses
Receivables $299.4K $116.5K $119.1K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $398.0K $308.5K $977.4K
YoY Change -41.85% -68.43% 221.58%
LONG-TERM ASSETS
Property, Plant & Equipment $1.461K $1.461K $74.14K
YoY Change -97.61% -98.03% -43.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $119.7K
YoY Change
Total Long-Term Assets $8.904K $22.01K $238.5K
YoY Change -96.05% -90.77% 80.88%
TOTAL ASSETS
Total Short-Term Assets $398.0K $308.5K $977.4K
Total Long-Term Assets $8.904K $22.01K $238.5K
Total Assets $406.9K $330.5K $1.216M
YoY Change -55.28% -72.82% 179.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.717M $2.611M $2.707M
YoY Change 1.85% -3.54% 2.56%
Accrued Expenses $5.881M $5.355M $4.619M
YoY Change 23.42% 15.94% 16.63%
Deferred Revenue
YoY Change
Short-Term Debt $8.407M $834.0K $864.0K
YoY Change 883.22% -3.47% -7.95%
Long-Term Debt Due $324.4K $7.715M $7.712M
YoY Change -95.7% 0.04% -7.15%
Total Short-Term Liabilities $17.46M $16.68M $16.07M
YoY Change 9.18% 3.78% 0.04%
LONG-TERM LIABILITIES
Long-Term Debt $150.0K $126.7K $302.5K
YoY Change -47.76% -58.1% -73.71%
Other Long-Term Liabilities $21.79K
YoY Change -70.54%
Total Long-Term Liabilities $150.0K $126.7K $324.3K
YoY Change -49.48% -60.92% -73.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.46M $16.68M $16.07M
Total Long-Term Liabilities $150.0K $126.7K $324.3K
Total Liabilities $17.61M $16.80M $16.39M
YoY Change 8.11% 2.5% -5.17%
SHAREHOLDERS EQUITY
Retained Earnings -$37.24M -$36.41M
YoY Change
Common Stock $699.4K $586.4K
YoY Change
Preferred Stock $76.69K
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$17.96M -$17.20M -$15.18M
YoY Change
Total Liabilities & Shareholders Equity $406.9K $330.5K $1.216M
YoY Change -55.28% -72.82% 179.01%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income -$830.7K -$781.7K -$853.0K
YoY Change 14.94% -8.36% -4250.71%
Depreciation, Depletion And Amortization $0.00
YoY Change -100.0%
Cash From Operating Activities -$187.2K -$133.5K -$349.6K
YoY Change -70.55% -61.81% 6175.94%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 102.4K $42.06K 145.4K
YoY Change -57.62% -71.07% -838.99%
NET CHANGE
Cash From Operating Activities -187.2K -$133.5K -349.6K
Cash From Investing Activities
Cash From Financing Activities 102.4K $42.06K 145.4K
Net Change In Cash -84.79K -$91.45K -204.2K
YoY Change -78.48% -55.22% 709.07%
FREE CASH FLOW
Cash From Operating Activities -$187.2K -$133.5K -$349.6K
Capital Expenditures
Free Cash Flow -$133.5K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 bant Lease Liabilities Noncurrent
LeaseLiabilitiesNoncurrent
usd
CY2022Q4 dei Document Type
DocumentType
10-Q
CY2022Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q4 dei Entity File Number
EntityFileNumber
000-55789
CY2022Q4 dei Entity Registrant Name
EntityRegistrantName
BANTEC, INC.
CY2022Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-0967943
CY2022Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
195 Paterson Avenue
CY2022Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Little Falls
CY2022Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07424
CY2022Q4 dei City Area Code
CityAreaCode
(203)
CY2022Q4 dei Local Phone Number
LocalPhoneNumber
220-2296
CY2022Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q4 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q4 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Security12g Title
Security12gTitle
Common
CY2022Q4 dei Trading Symbol
TradingSymbol
BANT
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6621329932 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94938 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
186386 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
116542 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
419951 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
92372 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
92917 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4663 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4663 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
308515 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
703917 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1461 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1461 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20544 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33568 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
22005 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
35029 usd
CY2022Q4 us-gaap Assets
Assets
330520 usd
CY2022Q3 us-gaap Assets
Assets
738946 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2611367 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2730309 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5355289 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5094394 usd
CY2022Q4 bant Convertible Notes Payable Net Of Discounts And Premiums
ConvertibleNotesPayableNetOfDiscountsAndPremiums
7446325 usd
CY2022Q3 bant Convertible Notes Payable Net Of Discounts And Premiums
ConvertibleNotesPayableNetOfDiscountsAndPremiums
7422326 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
834000 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
837000 usd
CY2022Q4 bant Notes And Loan Payable Current
NotesAndLoanPayableCurrent
268964 usd
CY2022Q3 bant Notes And Loan Payable Current
NotesAndLoanPayableCurrent
217897 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
13537 usd
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
139562 usd
CY2022Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
154562 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21111 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
34475 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16676618 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16504500 usd
CY2022Q4 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
126740 usd
CY2022Q3 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
127539 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
126740 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
127539 usd
CY2022Q4 us-gaap Liabilities
Liabilities
16803358 usd
CY2022Q3 us-gaap Liabilities
Liabilities
16632039 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
722400 usd
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
685440 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5864107732 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5864107732 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4407320832 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4407320832 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
586412 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
440733 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18630211 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18610920 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36411861 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35630186 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-17195238 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-16578533 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
330520 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
738946 usd
CY2022Q4 us-gaap Revenues
Revenues
606166 usd
CY2021Q4 us-gaap Revenues
Revenues
402117 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
511216 usd
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
307300 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
94950 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
94817 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
514290 usd
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
654296 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
514290 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
654296 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-419340 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-559479 usd
CY2021Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
677 usd
CY2022Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-362335 usd
CY2021Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-294170 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-362335 usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-293493 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-781675 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-852972 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-781675 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-852972 usd
CY2022Q4 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
36960 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-818635 usd
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-852972 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5327269482 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2590178717 shares
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-16578533 usd
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
99333 usd
CY2022Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
102597 usd
CY2022Q4 us-gaap Dividends Preferred Stock
DividendsPreferredStock
36960 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-781675 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-17195238 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14796078 usd
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
34934 usd
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
250000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
185850 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-852972 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-15178266 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-781675 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-852972 usd
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
91009 usd
CY2021Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
29697 usd
CY2022Q4 us-gaap Accretion Expense
AccretionExpense
57000 usd
CY2021Q4 us-gaap Accretion Expense
AccretionExpense
74616 usd
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
34934 usd
CY2022Q4 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
9885 usd
CY2022Q4 bant Gain Loss On Fee Notes Issued
GainLossOnFeeNotesIssued
57000 usd
CY2021Q4 bant Gain Loss On Fee Notes Issued
GainLossOnFeeNotesIssued
45000 usd
CY2021Q4 bant Gain Loss On Derivative Change In Fair Market Value
GainLossOnDerivativeChangeInFairMarketValue
677 usd
CY2022Q4 bant Accounts Receivable
AccountsReceivable
303409 usd
CY2021Q4 bant Accounts Receivable
AccountsReceivable
9335 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-545 usd
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7625 usd
CY2021Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-21767 usd
CY2022Q4 bant Incrase Decrease In Net Change Right Of Use Asset And Lease
IncraseDecreaseInNetChangeRightOfUseAssetAndLease
340 usd
CY2022Q4 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
144664 usd
CY2021Q4 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
296354 usd
CY2022Q4 bant Increase Decrease In Settlement Payable
IncreaseDecreaseInSettlementPayable
15000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-133503 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-349571 usd
CY2021Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4885 usd
CY2022Q4 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
24000 usd
CY2021Q4 bant Repayments Of Factoring Notes
RepaymentsOfFactoringNotes
142006 usd
CY2022Q4 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
37537 usd
CY2022Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
40741 usd
CY2022Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
99333 usd
CY2021Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
250000 usd
CY2021Q4 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
51250 usd
CY2022Q4 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
3000 usd
CY2021Q4 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
9000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42055 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
145359 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-91448 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-204212 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
186386 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
985953 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
94938 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
781741 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
16164 usd
CY2022Q4 bant Reclassification Of Debt Premium Upon Conversion
ReclassificationOfDebtPremiumUponConversion
45000 usd
CY2021Q4 bant Reclassification Of Debt Premium Upon Conversion
ReclassificationOfDebtPremiumUponConversion
63000 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
47712 usd
CY2021Q4 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
122850 usd
CY2021Q4 bant Original Issue Discounts Notes
OriginalIssueDiscountsNotes
3750 usd
CY2022Q4 us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 - <span style="font-variant: small-caps"><span style="text-decoration:underline">NATURE OF OPERATIONS</span></span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bantec, Inc. is product and service company targeting the U.S. Government, state governments, municipalities, hospitals, universities, manufacturers and other building owners. Bantec also provides product procurement, distribution, and logistics services through its wholly-owned subsidiary, Howco Distributing Co., (“Howco”) (collectively, the “Company”) to the United States Department of Defense and Defense Logistics Agency. The Company established Bantec Sanitizing in fiscal 2021, which offers sanitizing products and equipment through its new store bantec.store. Bantec Sanitizing is currently offering Bantec Sanitizing franchises for sale. The Company has operations based in Little Falls, New Jersey and Vancouver, Washington. The Company continues to seek strategic acquisitions and partnerships that offer us an opportunity to grow sales and profit.</p>
CY2022Q4 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
781675 usd
CY2022Q4 us-gaap Cash Including Discontinued Operations
CashIncludingDiscontinuedOperations
133503 usd
CY2022Q4 bant Working Capital Deficit
WorkingCapitalDeficit
16368103 usd
CY2022Q4 us-gaap Stockholders Equity Other
StockholdersEquityOther
17195238 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36411861 usd
CY2022Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the allowance for bad debt on accounts receivable, reserves on inventory, valuation of intangible assets for impairment analysis, valuation of the lease liability and related right-of-use asset, valuation of stock-based compensation, valuation of redeemable preferred stock and the valuation allowance on deferred tax assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p>
CY2022Q4 us-gaap Recapitalization Costs
RecapitalizationCosts
2000 usd
CY2022Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2022 bant Salvageable Value
SalvageableValue
1461 usd
CY2022Q4 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
12920 usd
CY2021Q4 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
15804 usd
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
156554 usd
CY2022Q4 bant Options Outstanding And Exercisable
OptionsOutstandingAndExercisable
16423 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2240000000 shares
CY2022Q4 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
9839057 usd
CY2022Q4 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
208587952309 shares
CY2022Q4 us-gaap Earnings Per Share Potentially Dilutive Securities
EarningsPerSharePotentiallyDilutiveSecurities
217,547,968,732
CY2022Q4 bant Shares Converted Percentage
SharesConvertedPercentage
0.0499 pure
CY2022Q4 bant Outstanding Shares Percentage
OutstandingSharesPercentage
0.0999 pure
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16423 shares
CY2021Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
17223 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2240000000 shares
CY2021Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
119777075 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
6720000000 shares
CY2022Q4 bant Incremental Common Shares Attributable To Sharebased Payment Arrangements Senior Convertible Debt
IncrementalCommonSharesAttributableToSharebasedPaymentArrangementsSeniorConvertibleDebt
208587952309 shares
CY2021Q4 bant Incremental Common Shares Attributable To Sharebased Payment Arrangements Senior Convertible Debt
IncrementalCommonSharesAttributableToSharebasedPaymentArrangementsSeniorConvertibleDebt
9105940574 shares
CY2022Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
217547968732 shares
CY2021Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9255734872 shares
CY2022Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On December 15, 2022 the Company filed Form PRE 14C to effect a reverse split of between 1:500 and 1:1,000 shares of common stock. The Company has determined that the definitive filing will be for a reverse split of 1:1,000. The Company expects processing in late February 2023. The table below shows the Losses Per Share prior to the reverse split and following the reverse split of 1:1,000. A key assumption to the earnings per share calculation is that post-reverse split price is equal to the pre-reverse split times the number of shares from the ratio. For example: pre-reverse split price of $0.003 times the reverse split of 1,000 is equal to $0.30. 
CY2022Q4 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
818635 usd
CY2021Q4 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
852972 usd
CY2022Q4 bant Current Weighted Average Shares Outstanding
CurrentWeightedAverageSharesOutstanding
5327269482 shares
CY2021Q4 bant Current Weighted Average Shares Outstanding
CurrentWeightedAverageSharesOutstanding
2590178717 shares
CY2022Q4 us-gaap Earnings Per Share Basic Distributed
EarningsPerShareBasicDistributed
0
CY2021Q4 us-gaap Earnings Per Share Basic Distributed
EarningsPerShareBasicDistributed
0
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
5327269 shares
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
2590179 shares
CY2022Q4 bant Loss Per Share
LossPerShare
0.15
CY2021Q4 bant Loss Per Share
LossPerShare
0.33
CY2022Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 pure
CY2022Q4 us-gaap Segment Reporting Description Of All Other Segments
SegmentReportingDescriptionOfAllOtherSegments
Howco generated 99% of the consolidated sales which are primarily from department of defense. Drone LLC generated less than 1% of sales primarily to state and municipal government purchases of drones and accessories. Bantec Sanitizing Inc. had no contribution to consolidated sales of its sanitizing products for the three months ended December 31, 2022. Howco has 77% of the consolidated tangible assets, Drone has no allocated assets and Bantec Sanitizing Inc. has 8% of consolidated assets and the parent company has 15% of the consolidated tangible assets as of December 31, 2022 and additionally, there are no formal cost allocations to Howco or the other subsidiaries.
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
116542 usd
CY2022Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
419951 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
116542 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
419951 usd
CY2022Q4 bant Bad Debt Expense
BadDebtExpense
0 usd
CY2021Q4 bant Bad Debt Expense
BadDebtExpense
3 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
92372 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
92917 usd
CY2022Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 usd
CY2022Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
50000 usd
CY2018Q3 bant Settlement Agreement Relating To Past Due Charges Amount
SettlementAgreementRelatingToPastDueChargesAmount
127056 usd
CY2020Q1 bant Initial Payment Amount
InitialPaymentAmount
12706 usd
CY2020Q1 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
6500 usd
CY2020Q1 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
3850 usd
CY2022Q2 us-gaap Payments For Fees
PaymentsForFees
7042 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
5000 usd
CY2022Q3 us-gaap Settlement Assets Current
SettlementAssetsCurrent
119670 usd
CY2022Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
139562 usd
CY2022 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
154562 usd
CY2021Q4 bant Conversion Discount
ConversionDiscount
0.50 pure
CY2022Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2017-09-09
CY2022Q4 bant Debt Instrument Interest Rates During Period
DebtInstrumentInterestRatesDuringPeriod
0.055 pure
CY2022Q4 bant Debt Instrument Default Interest Rate
DebtInstrumentDefaultInterestRate
0.08 pure
CY2022Q4 bant Amortization Of Debt Discounts Premium
AmortizationOfDebtDiscountsPremium
0 usd
CY2021Q4 bant Amortization Of Debt Discounts Premium
AmortizationOfDebtDiscountsPremium
7865 usd
CY2016Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
7000 shares
CY2017Q2 bant Debt Instrument Embedded Conversion Amount
DebtInstrumentEmbeddedConversionAmount
617647 usd
CY2017Q2 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.25 pure
CY2018Q3 bant Debt Instrument Convertible Conversion Rate Description
DebtInstrumentConvertibleConversionRateDescription
the Company’s senior lender amended its credit facility which had been restructured in January 2018 when fees for advisory and other matters along with accrued but unpaid interest were capitalized and separated into two notes, Note A having $1,000,000 principal and Note B having $4,788,642 both having the same maturity terms, interest rates and conversion rights.
CY2019Q4 bant Securities Shares Issued
SecuritiesSharesIssued
1273261 shares
CY2018Q4 bant Securities Shares Issued
SecuritiesSharesIssued
101624 shares
CY2019Q4 bant Shares Cancelled
SharesCancelled
194520 shares
CY2018 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
308100 usd
CY2019 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
270320 usd
CY2022Q4 bant Convertible Debt Balance Amount
ConvertibleDebtBalanceAmount
421587 usd
CY2022Q4 bant Extinguishment Of Debt Description
ExtinguishmentOfDebtDescription
Under the agreement the Company will issue to Frondeur Partners LLC convertible fee notes having principal of $15,000, interest of 10% per annum, maturity of seven months. The notes are convertible into common shares at a discount of 50% to the lowest bid price in the twenty trading days immediately preceding the notice of conversion. The notes are charged to professional fees for each corresponding service month. The principal balance for the Frondeur notes was $105,000 and accrued interest for the notes totaled $3,332 at December 31, 2022, as detailed below.On March 1, 2022, the Company issued a convertible promissory note to Frondeur Partners LLC for $15,000 in principal for services (service agreement replacing agreement with Livingston Asset Management LLC). The convertible note bears interest of 10% per annum and matures in nine months. The note issued is convertible into shares of common stock at a discount of 50% of the lowest closing bid price during the thirty trading days prior to conversion. The note has a conversion feature and is treated as stock settled debt under ASC 480 and a debt premium of $15,000 is recognized as interest expense on note issuance date. At September 30, 2022 the accrued interest was $820. On October 3, 2022, the Company issued 191,826,700 shares of common stock in conversion of Frondeur Partners LLC, convertible note payable dated March 1, 2022, all principal of $15,000 and accrued interest of $888 were converted. Premium of $15,000 was reclassified to additional paid in capital. On April 1, 2022, the Company issued a convertible promissory note to Frondeur Partners LLC for $15,000 in principal for services (service agreement replacing agreement with Livingston Asset Management LLC). The convertible note bears interest of 10% per annum and matures in nine months. The note issued is convertible into shares of common stock at a discount of 50% of the lowest closing bid price during the thirty trading days prior to conversion. The note has a conversion feature and is treated as stock settled debt under ASC 480 and a debt premium of $15,000 is recognized as interest expense on note issuance date. At September 30, 2022 the accrued interest was $752. On November 17, 2022, the Company issued 384,804,200 shares of common stock in conversion of Frondeur Partners LLC, convertible note payable dated April 1, 2022, all principal of $15,000 and accrued interest of $945 were converted. Premium of $15,000 was reclassified to additional paid in capital. On May 1, 2022, the Company issued a convertible promissory note to Frondeur Partners LLC for $15,000 in principal for services (service agreement replacing agreement with Livingston Asset Management LLC). The convertible note bears interest of 10% per annum and matures in nine months. The note issued is convertible into shares of common stock at a discount of 50% of the lowest closing bid price during the thirty trading days prior to conversion. The note has a conversion feature and is treated as stock settled debt under ASC 480 and a debt premium of $15,000 is recognized as interest expense on note issuance date. At September 30, 2022 the accrued interest was $629. On December 1, 2022, the Company issued 383,489,000 shares of common stock in conversion of Frondeur Partners LLC, convertible note payable dated May 1, 2022, all principal of $15,000 and accrued interest of $879 were converted. Premium of $15,000 was reclassified to additional paid in capital. On June 1, 2022, the Company issued a convertible promissory note to Frondeur Partners LLC for $15,000 in principal for services (service agreement replacing agreement with Livingston Asset Management LLC). The convertible note bears interest of 10% per annum and matures in nine months. The note issued is convertible into shares of common stock at a discount of 50% of the lowest closing bid price during the thirty trading days prior to conversion. The note has a conversion feature and is treated as stock settled debt under ASC 480 and a debt premium of $15,000 is recognized as interest expense on note issuance date. At December 31, 2022, and September 30, 2022 the accrued interest was $879 and $501, respectively. On July 1, 2022, the Company issued a convertible promissory note to Frondeur Partners LLC for $15,000 in principal for services (service agreement replacing agreement with Livingston Asset Management LLC). The convertible note bears interest of 10% per annum and matures in nine months. The note issued is convertible into shares of common stock at a discount of 50% of the lowest closing bid price during the thirty trading days prior to conversion. The note has a conversion feature and is treated as stock settled debt under ASC 480 and a debt premium of $15,000 is recognized as interest expense on note issuance date. At December 31, 2022 and September 30, 2022, the accrued interest was $692 and $314, respectively. On August 1, 2022, the Company issued a convertible promissory note to Frondeur Partners LLC for $15,000 in principal for services (service agreement replacing agreement with Livingston Asset Management LLC). The convertible note bears interest of 10% per annum and matures in nine months. The note issued is convertible into shares of common stock at a discount of 50% of the lowest closing bid price during the thirty trading days prior to conversion. The note has a conversion feature and is treated as stock settled debt under ASC 480 and a debt premium of $15,000 is recognized as interest expense on note issuance date. At December 31, 2022, and September 30, 2022 the accrued interest was $565 and $187, respectively. On September 1, 2022, the Company issued a convertible promissory note to Frondeur Partners LLC for $15,000 in principal for services (service agreement replacing agreement with Livingston Asset Management LLC). The convertible note bears interest of 10% per annum and matures in nine months. The note issued is convertible into shares of common stock at a discount of 50% of the lowest closing bid price during the thirty trading days prior to conversion. The note has a conversion feature and is treated as stock settled debt under ASC 480 and a debt premium of $15,000 is recognized as interest expense on note issuance date. At December 31, 2022, and September 30, 2022 the accrued interest was $440 and $62. On October 1, 2022, the Company issued a convertible promissory note to Frondeur Partners LLC for $15,000 in principal for services (service agreement replacing agreement with Livingston Asset Management LLC). The convertible note bears interest of 10% per annum and matures in nine months. The note issued is convertible into shares of common stock at a discount of 50% of the lowest closing bid price during the thirty trading days prior to conversion. The note has a conversion feature and is treated as stock settled debt under ASC 480 and a debt premium of $15,000 is recognized as interest expense on note issuance date. At December 31, 2022, the accrued interest was $378. On November 1, 2022, the Company issued a convertible promissory note to Frondeur Partners LLC for $15,000 in principal for services (service agreement replacing agreement with Livingston Asset Management LLC). The convertible note bears interest of 10% per annum and matures in nine months. The note issued is convertible into shares of common stock at a discount of 50% of the lowest closing bid price during the thirty trading days prior to conversion. The note has a conversion feature and is treated as stock settled debt under ASC 480 and a debt premium of $15,000 is recognized as interest expense on note issuance date. At December 31, 2022, the accrued interest was $251. On December 1, 2022, the Company issued a convertible promissory note to Frondeur Partners LLC for $15,000 in principal for services (service agreement replacing agreement with Livingston Asset Management LLC). The convertible note bears interest of 10% per annum and matures in nine months. The note issued is convertible into shares of common stock at a discount of 50% of the lowest closing bid price during the thirty trading days prior to conversion. The note has a conversion feature and is treated as stock settled debt under ASC 480 and a debt premium of $15,000 is recognized as interest expense on note issuance date. At December 31, 2022, the accrued interest was $127. The principal balance for the Frondeur notes was $105,000 at December 31, and September 30, 2022, respectively, as detailed above. Accrued interest for these notes totaled $3,332 and $3,631 at December 31, and September 30, 2022 , respectively also detailed above.  The following notes have been issued to the law firm, each having six-month term to maturity and 10% annual interest but a change in the conversion terms such that a fixed discount of 50% of the lowest bid price in the 30 trading days immediately preceding the notice of conversion. The notes have cross default provisions. The Company has accounted for the convertible promissory notes as stock settled debt under ASC 480 and recorded debt premiums equal to the face value of the notes with a charge to interest expense. The note principal amount was charged to professional fees during the month the note was issued. On May 1, 2022, a $4,000 convertible note was issued for fees incurred; On June 1, 2022, a $4,000 convertible note was issued for fees incurred; On July 1, 2022, a $4,000 convertible note was issued for fees incurred; On August 1, 2022, a $4,000 convertible note was issued for fees incurred; On September 1, 2022, a $4,000 convertible note was issued for fees incurred; On October 1, 2022, a $4,000 convertible note was issued for fees incurred; On November 1, 2022, a $4,000 convertible note was issued for fees incurred; and On December 1, 2022, a $4,000 convertible note was issued for fees incurred. The principal balances owed under the agreement as of December 31, 2022 and September 30, 2022 were $32,000, and $20,000 respectively and accrued interest was $1,235 and $563 as of December 31, 2022, and September 30, 2022, respectively. CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTSOn November 13, 2018, the Company issued a convertible promissory note for $90,000 to a vendor in settlement of approximately $161,700 of past due amounts due for services. The note bears interest at 5%, matures on June 30, 2019 and is convertible into the Company’s common stock at 50% of the lowest closing bid price during the 20 trading days immediately preceding the notice of conversion. The note matured on June 30, 2019, there is no default penalty or interest rate increase associated with the note, nor are there any cross-default provisions in the note. The Company has accounted for the convertible promissory note as stock settled debt under ASC 480 and recorded debt premium $90,000 with a charge to interest expense for the notes.
CY2021Q4 bant Debt Instrument Principal Amount
DebtInstrumentPrincipalAmount
15000 usd
CY2021Q4 bant Notes Bears Interest
NotesBearsInterest
0.10 pure
CY2022Q4 us-gaap-sup Debt Instrument Issued Principal
DebtInstrumentIssuedPrincipal
105000 usd
CY2022Q1 bant Debt Instrument Principal Amount
DebtInstrumentPrincipalAmount
15000 usd
CY2022Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
191826700 shares
CY2022Q1 bant Debt Instrument Annual Principal Payments
DebtInstrumentAnnualPrincipalPayments
15000 usd
CY2022Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
888 usd
CY2022Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
15000 usd
CY2022Q2 bant Debt Instrument Principal Amount
DebtInstrumentPrincipalAmount
15000 usd
CY2022Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2022Q2 bant Conversion Discount
ConversionDiscount
0.50 pure
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000 usd
CY2022Q4 bant Conversion Shares Of Common Stock1
ConversionSharesOfCommonStock1
384804200 shares
CY2022Q4 bant Debt Instrument Annual Principal Payments
DebtInstrumentAnnualPrincipalPayments
15000 usd
CY2022Q4 bant Accrued Interests
AccruedInterests
945 usd
CY2022Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
15000 usd
CY2022Q2 bant Debt Instrument Principal Amount
DebtInstrumentPrincipalAmount
15000 usd
CY2022Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2022Q1 bant Conversion Discount
ConversionDiscount
0.50 pure
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000 usd
CY2022Q2 bant Debt Instrument Annual Principal Payments
DebtInstrumentAnnualPrincipalPayments
15000 usd
CY2022Q2 us-gaap Debt Conversion Description
DebtConversionDescription
$879
CY2022Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
15000 usd
CY2022Q2 bant Debt Instrument Principal Amount
DebtInstrumentPrincipalAmount
15000 usd
CY2022Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2022Q1 bant Conversion Discount
ConversionDiscount
0.50 pure
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
15000 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2022Q3 bant Conversion Discount
ConversionDiscount
0.50 pure
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000 usd
CY2022Q3 bant Debt Instrument Annual Principal Payments
DebtInstrumentAnnualPrincipalPayments
15000 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000 usd
CY2022Q3 bant Accrued Interests
AccruedInterests
187 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
15000 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000 usd
CY2022Q4 bant Debt Instrument Principal Amount
DebtInstrumentPrincipalAmount
15000 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2022Q4 bant Conversion Discount
ConversionDiscount
0.50 pure
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000 usd
CY2022Q4 bant Debt Instrument Principal Amount
DebtInstrumentPrincipalAmount
15000 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2022Q3 bant Conversion Discount
ConversionDiscount
0.50 pure
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000 usd
CY2022Q4 bant Debt Instrument Principal Amount
DebtInstrumentPrincipalAmount
15000 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2021 bant Deposit Liabilitie Accrued Interest1
DepositLiabilitieAccruedInterest1
3631 usd
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15000 usd
CY2022Q4 bant Conversion Discount
ConversionDiscount
0.50 pure
CY2022Q4 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2022Q4 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.50 pure
CY2022 bant Frondeur Notes
FrondeurNotes
105000 usd
CY2022Q4 bant Frondeur Notes
FrondeurNotes
105000 usd
CY2022Q4 bant Deposit Liabilitie Accrued Interest1
DepositLiabilitieAccruedInterest1
3332 usd
CY2019Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
4000 usd
CY2019Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
4000 usd
CY2020Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
4000 usd
CY2022Q2 bant Convertible Note Issuance
ConvertibleNoteIssuance
4000 usd
CY2022Q2 bant Convertible Note Issuance
ConvertibleNoteIssuance
4000 usd
CY2022Q3 bant Convertible Note Issuance
ConvertibleNoteIssuance
4000 usd
CY2022Q3 bant Convertible Note Issuance
ConvertibleNoteIssuance
4000 usd
CY2022Q3 bant Convertible Note Issuance
ConvertibleNoteIssuance
4000 usd
CY2022Q4 bant Agreement Owned Amount
AgreementOwnedAmount
32000 usd
CY2022 bant Agreement Owned Amount
AgreementOwnedAmount
20000 usd
CY2018Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
90000 usd
CY2018Q4 bant Vendor Settlement
VendorSettlement
161700 usd
CY2018Q4 us-gaap Debt Conversion Description
DebtConversionDescription
The note bears interest at 5%, matures on June 30, 2019 and is convertible into the Company’s common stock at 50% of the lowest closing bid price during the 20 trading days immediately preceding the notice of conversion.
CY2018Q4 bant Debt Premium Charge To Interest Expense
DebtPremiumChargeToInterestExpense
90000 usd
CY2022Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
90000 usd
CY2022Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
90000 usd
CY2022Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
574759 usd
CY2022Q3 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
615500 usd
CY2022Q4 bant Debt Instrument Discount Amount
DebtInstrumentDiscountAmount
179055 usd
CY2022Q3 bant Debt Instrument Discount Amount
DebtInstrumentDiscountAmount
270064 usd
CY2022Q4 bant Debt Instrument Total
DebtInstrumentTotal
395704 usd
CY2022Q3 bant Debt Instrument Total
DebtInstrumentTotal
345436 usd
CY2022Q4 bant Less Current Portions
LessCurrentPortions
268964 usd
CY2022Q3 bant Less Current Portions
LessCurrentPortions
217897 usd
CY2022Q4 bant Noncurrent
Noncurrent
126740 usd
CY2022Q3 bant Noncurrent
Noncurrent
127539 usd
CY2022Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
91009 usd
CY2021Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7865 usd
CY2020Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P1Y
CY2021Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
150000 usd
CY2022Q4 bant Classified Current Interest
ClassifiedCurrentInterest
23260 usd
CY2022 bant Classified Current Interest
ClassifiedCurrentInterest
22461 usd
CY2021 bant Number Of Notes Payable
NumberOfNotesPayable
seven
CY2021Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
17500 usd
CY2021 bant Service Vendor Fee
ServiceVendorFee
-2500 usd
CY2021 us-gaap Debt Instrument Term
DebtInstrumentTerm
P1Y
CY2022Q4 bant Service Arrangement
ServiceArrangement
17500 usd
CY2022 bant Service Arrangement
ServiceArrangement
17500 usd
CY2022Q4 us-gaap Preferred Stock Convertible Conversion Price Increase
PreferredStockConvertibleConversionPriceIncrease
0.0002
CY2022Q4 bant Debt Instrument Convertible Conversion Price
DebtInstrumentConvertibleConversionPrice
0.50 pure
CY2022Q4 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.50 pure
CY2022Q4 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
101368 usd
CY2022Q4 us-gaap Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
461440 usd
CY2022Q3 bant Additional Paid In Capital Including Dividends
AdditionalPaidInCapitalIncludingDividends
360072 usd
CY2022 us-gaap Investment Income Dividend
InvestmentIncomeDividend
13440 usd
CY2020Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
36960 usd
CY2022Q4 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
1.5
CY2022Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0002
CY2022Q4 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
0.50 pure
CY2022Q4 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
224000 usd
CY2022Q4 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.22 pure
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
3999750 shares
CY2022Q4 bant Common Stock Dividend
CommonStockDividend
0.99
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5864107732 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4407320832 shares
CY2022Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
the Company filed form PRE 14C with the SEC announcing its intent to effect a reverse stock split with a ratio of between 1:500 or 1:1,000. The Company has determined to fix the reverse split ratio at 1:1,000.
CY2022Q3 bant Issuance Settled Amount Due Description
IssuanceSettledAmountDueDescription
The offering provides for the issuance of up to 5,000,000,000 shares of common stock at a price of $.0002, under subscriptions.
CY2022Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
496667000 shares
CY2022Q4 bant Offering And Recieved
OfferingAndRecieved
99333 usd
CY2022Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
960119900 shares
CY2022Q4 us-gaap Convertible Debt
ConvertibleDebt
45000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34934 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16423 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
220
CY2022 bant Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
P1Y11M19D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16423 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
220
CY2022 bant Weighted Average Remaining Contractual Term Years Outstanding Beginning
WeightedAverageRemainingContractualTermYearsOutstandingBeginning
P1Y8M19D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
16423 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
220
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y8M19D
CY2022Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
24000 usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2240000000 shares
CY2021Q3 bant Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices
0.0002
CY2022 bant Weighted Average Remaining Contractual Term Years Outstanding And Exercisable Begining
WeightedAverageRemainingContractualTermYearsOutstandingAndExercisableBegining
P6Y9M
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.0002
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
448000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2240000000 shares
CY2022Q4 bant Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices
0.0002
CY2022Q4 bant Weighted Average Remaining Contractual Term Years Outstanding And Exercisable Ending
WeightedAverageRemainingContractualTermYearsOutstandingAndExercisableEnding
P6Y6M
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.0002
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
112000 usd
CY2022Q4 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.90 pure
CY2022Q4 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 usd
CY2021Q4 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 usd
CY2022Q4 bant Employees Contribution Plans Term
EmployeesContributionPlansTerm
P1Y
CY2022Q4 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
1063 usd
CY2021Q4 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
1835 usd
CY2016Q4 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
370000 usd
CY2022Q4 us-gaap Loss On Contract Termination
LossOnContractTermination
2500000 usd
CY2019Q3 bant Annual Salary
AnnualSalary
624000 usd
CY2021Q4 bant Interest Expenses
InterestExpenses
156000 usd
CY2022Q4 us-gaap Debt Instrument Frequency Of Periodic Payment
DebtInstrumentFrequencyOfPeriodicPayment
$3,000
CY2021Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
36821330 shares
CY2022 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
119670 shares
CY2019Q2 us-gaap Valuation Allowance For Impairment Of Recognized Servicing Assets Provisions
ValuationAllowanceForImpairmentOfRecognizedServicingAssetsProvisions
218637 usd
CY2019Q3 bant Past Due Amounts
PastDueAmounts
59000 usd
CY2020Q4 bant Lawsuit Seeking Payment
lawsuitSeekingPayment
276430 usd
CY2020Q4 bant Finance Charge
FinanceCharge
40212 usd
CY2022Q4 us-gaap Other Commitments Description
OtherCommitmentsDescription
The agreement has an initial term of three years with one year renewals.
CY2017Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
360000 usd
CY2020Q2 us-gaap Lessor Operating Lease Description
LessorOperatingLeaseDescription
On April 16, 2020 the Company’s subsidiary Howco renewed its office and warehouse lease in Vancouver, WA for a term commencing on June 1, 2020 extending through June 1, 2023 at an initial monthly rent of approximately $5,154.
CY2022Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
156554 usd
CY2022Q4 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.10 pure
CY2022Q4 bant Operating Lease At Inception
OperatingLeaseAtInception
156554 usd
CY2022Q3 bant Operating Lease At Inception
OperatingLeaseAtInception
156554 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
136010 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
122986 usd
CY2022Q4 bant Right Of Use Asset
RightOfUseAsset
20544 usd
CY2022Q3 bant Right Of Use Asset
RightOfUseAsset
33568 usd
CY2022Q4 bant Operating Lease Liabilities At Inception
OperatingLeaseLiabilitiesAtInception
156554 usd
CY2022Q3 bant Operating Lease Liabilities At Inception
OperatingLeaseLiabilitiesAtInception
156554 usd
CY2022Q4 bant Reduction Of Lease Liabilities
ReductionOfLeaseLiabilities
135443 usd
CY2022Q3 bant Reduction Of Lease Liabilities
ReductionOfLeaseLiabilities
122079 usd
CY2022Q4 bant Total Lease Liabilities Related To Rou
TotalLeaseLiabilitiesRelatedToRou
21111 usd
CY2022Q3 bant Total Lease Liabilities Related To Rou
TotalLeaseLiabilitiesRelatedToRou
34475 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
26830 usd
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
42929 usd
CY2022Q4 bant Discount To Fair Value
DiscountToFairValue
5719 usd
CY2022Q3 bant Discount To Fair Value
DiscountToFairValue
8454 usd
CY2022Q4 bant Total Lease Liability Rou
TotalLeaseLiabilityROU
21111 usd
CY2022Q3 bant Total Lease Liability Rou
TotalLeaseLiabilityROU
34475 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
26830 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
26830 usd
CY2022Q4 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
19562 usd
CY2021Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
17214 usd
CY2019Q4 us-gaap Lessor Operating Lease Description
LessorOperatingLeaseDescription
In December 2019, the Company relocated its primary office to 195 Paterson Avenue, Little Falls, New Jersey, under a one-year lease with a renewal option having monthly payments of $500. 
CY2022Q4 bant Employees Earned Salary
EmployeesEarnedSalary
0 usd
CY2021Q4 bant Employees Earned Salary
EmployeesEarnedSalary
0 usd
CY2022Q4 bant Federally Insured Limit Amount
FederallyInsuredLimitAmount
250000 usd
CY2023Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
4000 usd
CY2023Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.10 pure
CY2023Q1 bant Fixed Discount Percentage
FixedDiscountPercentage
0.50 pure
CY2022Q4 dei Security Exchange Name
SecurityExchangeName
NONE
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2021Q4 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2022Q4 bant Gain Loss On Derivative Change In Fair Market Value
GainLossOnDerivativeChangeInFairMarketValue
usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
CY2021Q4 bant Incrase Decrease In Net Change Right Of Use Asset And Lease
IncraseDecreaseInNetChangeRightOfUseAssetAndLease
usd
CY2021Q4 bant Increase Decrease In Settlement Payable
IncreaseDecreaseInSettlementPayable
usd
CY2022Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
CY2021Q4 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
CY2021Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
shares
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
usd
CY2022Q4 bant Repayments Of Factoring Notes
RepaymentsOfFactoringNotes
usd
CY2021Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
usd
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2022Q4 bant Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueExercisableNumber
usd
CY2022Q4 bant Less Current Portion
LessCurrentPortion
usd
CY2022Q3 bant Less Current Portion
LessCurrentPortion
usd
CY2022Q4 bant Lease Liabilities Noncurrent
LeaseLiabilitiesNoncurrent
usd
CY2022Q4 bant Original Issue Discounts Notes
OriginalIssueDiscountsNotes
usd
CY2022Q4 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001704795

Files In Submission

Name View Source Status
0001213900-23-012758-index-headers.html Edgar Link pending
0001213900-23-012758-index.html Edgar Link pending
0001213900-23-012758.txt Edgar Link pending
0001213900-23-012758-xbrl.zip Edgar Link pending
bant-20221231.xsd Edgar Link pending
f10q1222ex31-1_bantecinc.htm Edgar Link pending
f10q1222ex31-2_bantecinc.htm Edgar Link pending
f10q1222ex32-1_bantecinc.htm Edgar Link pending
f10q1222_bantecinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
bant-20221231_cal.xml Edgar Link unprocessable
bant-20221231_def.xml Edgar Link unprocessable
bant-20221231_lab.xml Edgar Link unprocessable
bant-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q1222_bantecinc_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending